EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stress‐induced Rab11a‐exosomes induce amphiregulin‐mediated cetuximab resistance in colorectal cancer

John D Mason, Ewan Marks, Shih-Jung Fan, Kristie McCormick, Clive Wilson, Adrian L Harris, Freddie C Hamdy, Chris Cunningham, Deborah C I Goberdhan iD

Journal of Extracellular Vesicles · 2024

DOI: 10.1002/jev2.12465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von John D Mason und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Amphiregulin, Cetuximab, Exosomes, Colorectal Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomes are secreted vesicles made intracellularly in the endosomal system. We have previously shown that exosomes are not only made in late endosomes, but also in recycling endosomes marked by the monomeric G‐protein Rab11a. These vesicles, termed Rab11a‐exosomes, are preferentially secreted under nutrient stress from several cancer cell types, including HCT116 colorectal cancer (CRC) cells. HCT116 Rab11a‐exosomes have particularly potent signalling activities, some mediated by the epidermal growth factor receptor (EGFR) ligand, amphiregulin (AREG). Mutant activating forms of KRAS, a downstream target of EGFR, are often found in advanced CRC. When absent, monoclonal antibodies, such as cetuximab, which target the EGFR and block the effects of EGFR ligands, such as AREG, can be administered. Patients, however, inevitably develop resistance to cetuximab, either by acquiring KRAS mutations or via non‐genetic microenvironmental changes. Here we show that nutrient stress in several CRC cell lines causes the release of AREG‐carrying Rab11a‐exosomes. We demonstrate that while soluble AREG has no effect, much lower levels of AREG bound to Rab11a‐exosomes from cetuximab‐resistant KRAS‐mutant HCT116 cells, can suppress the effects of cetuximab on KRAS‐wild type Caco‐2 CRC cells. Using neutralising anti‐AREG antibodies and an intracellular EGFR kinase inhibitor, we show that this effect is mediated via AREG activation of EGFR, and not transfer of activated KRAS. Therefore, presentation of AREG on Rab11a‐exosomes affects its ability to compete with cetuximab. We propose that this Rab11a‐exosome‐mediated mechanism contributes to the establishment of resistance in cetuximab‐sensitive cells and may explain why in cetuximab‐resistant tumours only some cells carry mutant KRAS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmphiregulinCetuximabExosomesColorectal Neoplasmsrab GTP-Binding ProteinsDrug Resistance, NeoplasmHumansErbB ReceptorsHCT116 CellsAntineoplastic Agents, ImmunologicalCell Line, TumorStress, PhysiologicalProto-Oncogene Proteins p21(ras)Signal Transductionrab11 GTP-Binding Proteins

Stichwörter der Autor:innen

AREGEGFRRab11a‐exosomecetuximabcolorectal cancerextracellular vesicle

Substanzen

AmphiregulinCetuximabrab GTP-Binding ProteinsErbB ReceptorsAntineoplastic Agents, ImmunologicalProto-Oncogene Proteins p21(ras)rab11 GTP-Binding ProteinsAREG protein, humanEGFR protein, humanKRAS protein, human

Autor:innen und Institutionen

  • Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
  • Department of Life Sciences, National Central University, Taoyuan City, Taiwan.
  • Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

ORCID-Profile: Deborah C I Goberdhan

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Cancer Research UK

Zitieren

APA

Mason, J. D., Marks, E., Fan, S. J., McCormick, K., Wilson, C., Harris, A. L., Hamdy, F. C., Cunningham, C., & Goberdhan, D. C. I. (2024). Stress‐induced Rab11a‐exosomes induce amphiregulin‐mediated cetuximab resistance in colorectal cancer. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12465

Vancouver

Mason JD, Marks E, Fan SJ, McCormick K, Wilson C, Harris AL, et al. Stress‐induced Rab11a‐exosomes induce amphiregulin‐mediated cetuximab resistance in colorectal cancer. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12465

BibTeX
@article{Mason2024,
  author = {Mason, John D and Marks, Ewan and Fan, Shih-Jung and McCormick, Kristie and Wilson, Clive and Harris, Adrian L and Hamdy, Freddie C and Cunningham, Chris and Goberdhan, Deborah C I},
  title = {Stress‐induced Rab11a‐exosomes induce amphiregulin‐mediated cetuximab resistance in colorectal cancer},
  journal = {Journal of Extracellular Vesicles},
  year = {2024},
  doi = {10.1002/jev2.12465}
}
Kostenlos starten →